Access cutting-edge cognitive impairment treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Fresno location
Access cognitive impairment specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cognitive impairment treatment provided free
Check if you qualify for this cognitive impairment clinical trial in Fresno, CA
No-Cost Study Care
Local to Fresno
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Sponsor: Duke University
Yes, this clinical trial (NCT04262206) has an active research site in Fresno, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cognitive impairment treatment options in Fresno, CA, this clinical trial (NCT04262206) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cognitive impairment specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cognitive impairment clinical trials near you to find additional studies recruiting in your area.
See all myalgic encephalomyelitis clinical trials recruiting in Fresno — not just this study.
Browse Myalgic Encephalomyelitis Trials in Fresno →